Prosecution Insights
Last updated: August 17, 2026

Examiner: SIPP, AMY R.

Tech Center 3700 • Art Units: 3775

This examiner grants 71% of resolved cases

Performance Statistics

71.0%
Allow Rate
+1.0% vs TC avg
588
Total Applications
+26.0%
Interview Lift
1198
Avg Prosecution Days
Based on 528 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
17.1%
§102 Novelty
42.9%
§103 Obviousness
35.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19175161 Curable Material Dispensing System And Methods Of Operating And Packaging The Same Non-Final OA Stryker Corporation
19029612 Surgical Tool System Including Semi-Flexible Contact Pin Mounts Non-Final OA Stryker Corporation
19137361 MEASUREMENT DEVICE AND DRILL GUIDE Non-Final OA Arthrex, Inc.
19074633 STERNAL CLOSURE SYSTEMS Non-Final OA ARTHREX, INC.
18974972 INTERVERTEBRAL IMPLANTS AND RELATED METHODS OF USE Non-Final OA GLOBUS MEDICAL, INC.
18969046 Femoral Neck Fracture Fixation Device Non-Final OA GLOBUS MEDICAL, INC.
18768520 CERCLAGE CABLE SYSTEM AND APPARATUS Final Rejection GLOBUS MEDICAL, INC.
19238875 METHODS AND DEVICES FOR SYNDESMOSIS TENSIONING Non-Final OA DePuy Synthes Products, Inc.
18900135 ADJUSTABLE NAVIGATED SURGICAL DRILL SHEATH Non-Final OA Medivis, Inc.
19070936 KINEMATICALLY ALIGNED ORTHOPAEDIC SURGICAL INSTRUMENT AND METHOD OF USING THE SAME IN AN ORTHOPAEDIC KNEE PROCEDURE Non-Final OA DePuy Ireland Unlimited Company
18643547 SURGICAL INSTRUMENT BOLT Final Rejection DePuy Ireland Unlimited Company
18459904 ACETABULAR CUP EXTRACTOR Final Rejection Shukla Medical
18057253 SURGICAL EXTRACTOR Final Rejection Shukla Medical
17724719 GLENOSPHERE BASE REMOVAL TOOL Non-Final OA Shukla Medical

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month